Our Vision for Retinal Health
At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye.
Visual impairment and blindness have a profound and devastating impact on the lives of the affected person, their families and society as a whole. Driven by our passion to improve care, we will transform the retinal health landscape by developing novel treatments and technologies, especially where nothing currently exists. Our ambition is clear - prevent vision loss in people at risk and preserve or restore vision in those with retinal diseases.
Science and innovation are at the core of the comprehensive pipeline portfolio we have built in Retinal Health, with the first assets already in clinical development.
Due to the multifactorial pathophysiology of retinal diseases, our approach is truly holistic:
- We are pathfinders – we challenge research standards, and explore new opportunities, allowing us to remain champions of human health
- We are experts – our growing community of retinal specialists benefits from our existing knowledge and insights in oncology, inflammation, neurodegeneration, fibrosis and cardiometabolism
- We are partners – we seek cutting-edge partnerships with other companies and academic institutions to complement our pipeline and advance diagnosis, treatment and delivery
We have pioneering perspectives on innovation in Retinal Health that will give people with eye diseases a perspective into a brighter future.
Click on the audio recording to listen to our vision
Audio file
Related Content
Retinal Diseases
Eyes on Retina. The Podcast.
In this podcast series, we hear from a range of retinal experts and people living with retinal diseases.
Retinal Diseases
A Clear Vision
As experts in Retinal Health, we aim to transform the retinal health landscape by developing novel treatments and technologies, especially where nothing currently exists.